Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours
Gaspard Suc(Inserm), Dimitri Arangalage, Aurélie Sannier(Inserm), Bernard Iung(Assistance Publique – Hôpitaux de Paris), Clémence Delhomme(Inserm), Jamila Khallou‐Laschet(Inserm), Baptiste Bazire(Lyon 1 Université), Phalla Ou(Assistance Publique – Hôpitaux de Paris), Éric Garbarz(Assistance Publique – Hôpitaux de Paris), Patrick Nataf(Hôpital Bichat-Claude-Bernard), Agnès Cachier(Hôpital Beaujon), Giuseppina Caligiuri(Inserm), Lydia Deschamps(Université Claude Bernard Lyon 1), Olivia Hentic(Université Paris Cité), Philippe Ruszniewski(Inserm), Louis de Mestier(Inserm)
Cited by 9
Related Papers
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
|Journal of the American Society of Echocardiography|2009|2.1k